← back to search

John N. Ratchford

Amgen (United States) · US
Area of research
Pathology and Forensic Medicine · Ophthalmology
Research interest
Research interests include Multiple Sclerosis Research Studies, Ocular Diseases and Behçet’s Syndrome, Peripheral Neuropathies and Disorders, and Glaucoma and retinal disorders.
h-index
28
citations
5,277
works
62
NIH funding
primary concept
email

Recent publications

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder
Neurology Neuroimmunology & Neuroinflammation 2021cited by 39position: middledoi
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder
Multiple Sclerosis and Related Disorders 2021cited by 34position: middledoi
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD
Multiple Sclerosis Journal 2021cited by 17position: middledoi
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
The Lancet 2019cited by 711position: middledoi
Neuromyelitis optica spectrum disorder
Neurology Neuroimmunology & Neuroinflammation 2019cited by 129position: middledoi
Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four‐year study
Annals of Neurology 2015cited by 380position: middledoi
Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
Multiple Sclerosis Journal 2015cited by 71position: middledoi
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis
JAMA Neurology 2013cited by 227position: middledoi
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study
The Lancet Neurology 2012cited by 295position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eliezer Katz · Psyadon Pharmaceuticals (United States)6 papers (2015–2021)Ho Jin Kim · National Cancer Center5 papers (2015–2021)Dean M. Wingerchuk · University of Colorado Denver5 papers (2015–2021)Ari Green · University of California, San Francisco5 papers (2012–2021)Jeffrey L. Bennett · University of Colorado Denver5 papers (2015–2021)Bruce Cree · California State University, Bakersfield5 papers (2015–2021)Gary Cutter · Epilepsy Foundation5 papers (2015–2021)Brian G. Weinshenker · Mayo Clinic5 papers (2015–2021)Orhan Aktaş · Düsseldorf University Hospital5 papers (2015–2021)Friedemann Paul · Max Delbrück Center5 papers (2015–2021)Hans‐Peter Hartung · The University of Sydney5 papers (2015–2021)Romain Marignier · Hospices Civils de Lyon4 papers (2019–2021)Dewei She · Amgen (United States)4 papers (2019–2021)Daniel Cimbora · Amgen (United States)4 papers (2019–2021) · 4 papers (2015–2021)Jörn Drappa · University of California, San Francisco4 papers (2019–2021)Kazuo Fujihara · Fukushima Medical University4 papers (2015–2021)Ciprian M. Crainiceanu · Johns Hopkins University3 papers (2012–2015)Gerard Barron · Viventia Bio (Canada)3 papers (2015–2019)Jiwon Oh · Johns Hopkins University3 papers (2012–2015)